This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Eunice Michelle Chua Cua: Innovator in Dynamic Focus Control Technology
Introduction: Eunice Michelle Chua Cua is a notable inventor based in Pasadena, CA (US). He has made significant contributions to the field of optical coherence tomography (OCT) through his innovative patent. His work focuses on enhancing the visualization of the retina and optic nerve head, which is crucial for investigating various diseases affecting these areas.
Latest Patents: Eunice holds a patent titled "System and method for dynamic focus control." This invention provides en face views of OCT volumes, which are essential for visualizing the retina and optic nerve head. The patent demonstrates a combination of real-time processing of OCT volumetric data for axial tracking. It also incorporates a Controllable Optical Element (COE) to achieve automated focus on depth-resolved en face layers extracted from a volume. This technology allows for high-resolution imaging throughout an extended depth range.
Career Highlights: Throughout his career, Eunice has focused on advancing optical technologies. His innovative approach to dynamic focus control has the potential to significantly improve diagnostic capabilities in ophthalmology. With a patent count of 1 patent, he continues to contribute to the field with his cutting-edge research.
Collaborations: Eunice has collaborated with notable professionals in his field, including Marinko Venci Sarunic and Yifan Jian. These collaborations have further enriched his research and development efforts.
Conclusion: Eunice Michelle Chua Cua is a pioneering inventor whose work in dynamic focus control technology is making waves in the field of optical coherence tomography. His contributions are vital for improving the understanding and diagnosis of retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile